Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Deloitte
Merck
Baxter
Express Scripts
Chubb
McKinsey
McKesson
Colorcon

Generated: December 12, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0326768.9

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYYA METHOD OF INTRAVENOUS INJECTION USING ULTRASOUND GUIDANCE, ADMINISTERED VIA A SINGLE CANNULA INTO THE LUMEN OF THE TARGET INCOMPETENT TRUNK VEINS OR BY DIRECT INJECTION INTO VARICOSITIES
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist